Alastair Compston

From WikiProjectMed
Jump to navigation Jump to search

Alastair Compston

CBE FRS FMedSci FRCP
Compston in 2016
Born (1948-01-23) 23 January 1948 (age 76)
EducationRugby School
Alma mater
Scientific career
FieldsNeurology
Institutions
ThesisMultiple Sclerosis and the HLA System (1978)
Websitewww.neuroscience.cam.ac.uk/directory/profile.php?AlastairCompston

David Alastair Standish Compston CBE FRS FMedSci FRCP[1] (born 23 January 1948)[2] is a British neurologist. He is an emeritus professor of neurology in the Department of Clinical Neurosciences at the University of Cambridge and an emeritus fellow of Jesus College, Cambridge.[3][4]

Education

Compston was educated at Rugby School followed by the medical school of Middlesex Hospital, where he was awarded a Bachelor of Medicine, Bachelor of Surgery degree.[when?] He completed his PhD on multiple sclerosis and the Human Leukocyte Antigen (HLA) system at the University of London graduating in 1978.[5]

Research and career

Compston's research focuses on the clinical science of human demyelinating disease including the discovery of genetic risk factors for multiple sclerosis and the introduction of alemtuzumab.[6][7][8] [9]

Compston was formerly Professor of Neurology at the University of Wales, president of the European Neurological Society and the Association of British Neurologists, and editor of the journal Brain.[1][10]

Awards and honours

Compston's work has been recognised by prizes including the Charcot Award; the K-J Zülch Prize; the World Federation of Neurology Medal; the John Dystel Prize; the Richard and Mary Cave Award of the Multiple Sclerosis Society of Great Britain; the Hughlings Jackson Medal; the Galen Medal; and the Association of British Neurologists Medal.[1]

Compston was elected a Fellow of the Royal Society (FRS) in 2016[1] and appointed Commander of the Order of the British Empire (CBE) in the 2016 New Year Honours for services to multiple-sclerosis treatment.[11] He was elected a fellow of the Academy of Medical Sciences,[when?] and a foreign member of the National Academy of Sciences of Germany[when?] and the National Academy of Medicine of the United States.[when?]

References

  1. ^ a b c d Anon (2016). "Professor Alastair Compston FRS". London: Royal Society. Archived from the original on 29 April 2016. One or more of the preceding sentences incorporates text from the royalsociety.org website where:

    "All text published under the heading 'Biography' on Fellow profile pages is available under Creative Commons Attribution 4.0 International License." --"Royal Society Terms, conditions and policies". Archived from the original on 25 September 2015. Retrieved 9 March 2016.{{cite web}}: CS1 maint: bot: original URL status unknown (link)
  2. ^ "Compston, Prof. (David) Alastair (Standish)". Who's Who. A & C Black. 2021. doi:10.1093/ww/9780199540884.013.U11616. (Subscription or UK public library membership required.)
  3. ^ "Professor Alastair Compston, Cambridge Neurosciene". Cambridge: University of Cambridge. Archived from the original on 4 March 2015.
  4. ^ "Prof Alastair Compston, CBE Authorised Biography". Debrett's. Archived from the original on 20 May 2016.
  5. ^ Compston, David Alistair Standish (1978). Multiple sclerosis and the HLA system (PhD thesis). University of London. OCLC 500408475.
  6. ^ Jones, Joanne L.; Phuah, Chia-Ling; Cox, Amanda L.; Thompson, Sara A.; Ban, Maria; Shawcross, Jacqueline; Walton, Amie; Sawcer, Stephen J.; Compston, Alastair; Coles, Alasdair J. (2009). "IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H)". Journal of Clinical Investigation. 119 (7): 2052–61. doi:10.1172/JCI37878. PMC 2701868. PMID 19546505.
  7. ^ The CAMMS223 Trial Investigators (2008). "Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis". New England Journal of Medicine. 359 (17): 1786–1801. doi:10.1056/NEJMoa0802670. PMID 18946064.{{cite journal}}: CS1 maint: numeric names: authors list (link)
  8. ^ The International Multiple Sclerosis Genetics Consortium (2007). "Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study". New England Journal of Medicine. 357 (9): 851–862. doi:10.1056/NEJMoa073493. PMID 17660530.
  9. ^ Alastair Compston's publications indexed by the Scopus bibliographic database. (subscription required)
  10. ^ Compston, Alastair (2004). "Editorial". Brain. 127 (8): 1689–1690. doi:10.1093/brain/awh240.
  11. ^ "No. 61450". The London Gazette (Supplement). 30 December 2015. p. N8.


Stub icon

This article about a British scientist is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://mdwiki.org/wiki/Alastair_Compston"